Literature DB >> 24993141

Increased complication rates after hip and knee arthroplasty in patients with cirrhosis of the liver.

John V Tiberi1, Viktor Hansen, Naglaa El-Abbadi, Hany Bedair.   

Abstract

BACKGROUND: Risk stratification is critical in patients with cirrhosis undergoing THAs and TKAs, as they may be more likely to have serious medical and surgical complications. As opposed to the Child-Pugh scoring system, which has limited use for orthopaedic surgeons inexperienced in assessing ascites and hepatic encephalopathy, the Model for End-stage Liver Disease (MELD) is an easily calculated, validated scoring system for severity of liver disease based on common laboratory values; however, its usefulness for predicting complications after elective arthroplasty has not been studied. QUESTIONS/PURPOSES: The purposes of this study were to determine the differences between patients with cirrhosis and control subjects in (1) hospital length of stay, discharge disposition, and readmission within 90 days; (2) early postoperative (90 days) medical complications potentially related to liver disease; (3) surgical complications within 90 days and any time after the procedure; (4) mortality rates after THA and TKA; and in addition, (5) to use the MELD score as a predictor for risk of complications and mortality.
METHODS: Institutional database query software used coding data identified 115 patients with liver cirrhosis before having THAs or TKAs from 2000 to 2012 and 115 control subjects without cirrhosis matched by age, sex, procedure, and year of surgery. Early postoperative and longer-term medical and surgical complications were compared. Regression analysis was used to determine a MELD score that predicted greater risk of complications.
RESULTS: Compared with matched control subjects, patients with cirrhosis had prolonged length of stay and higher rates of discharge to nursing facilities, readmission in 90 days, and urinary tract infections (p < 0.01), renal failure (p = 0.03), blood transfusions (p < 0.01), gastrointestinal hemorrhage (p = 0.04), dislocations (p = 0.01), infections (p = 0.02), and revisions (p = 0.04) within 90 days. One-year (p = 0.01) and longer-term (p = 0.0002) mortality rates were greater in patients with cirrhosis. A MELD score of 10 or greater predicted a three times increased likelihood (odds ratio [OR]) of any complication (95% CI, 1.28-7.00; p = 0.01) and 4.1 times increased likelihood (OR) of death (95% CI, 1.42-11.86; p < 0.01).
CONCLUSIONS: Patients with cirrhosis undergoing THAs and TKAs should be counseled regarding their increased risk of medical complications, surgical complications, and death. A MELD score of 10 or greater is associated with a high rate of complications, although this finding needs further validation because we were unable to control for all medical confounders. LEVEL OF EVIDENCE: Level III, prognostic study. See the Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2014        PMID: 24993141      PMCID: PMC4117879          DOI: 10.1007/s11999-014-3681-z

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

Review 1.  Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?

Authors:  E Cholongitas; G V Papatheodoridis; M Vangeli; N Terreni; D Patch; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2005-12       Impact factor: 8.171

2.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Authors:  M Malinchoc; P S Kamath; F D Gordon; C J Peine; J Rank; P C ter Borg
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

3.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

4.  Operative risk of total hip and knee arthroplasty in cirrhotic patients.

Authors:  Stanley Martin Cohen; Helen S Te; Josh Levitsky
Journal:  J Arthroplasty       Date:  2005-06       Impact factor: 4.757

5.  Prosthetic hip infection in patients with liver cirrhosis: an outcome analysis.

Authors:  Pang-Hsin Hsieh; Steve W Ueng; Mel S Lee; Hsin-Nung Shih; Kuo-Chin Huang
Journal:  Int J Infect Dis       Date:  2010-10-08       Impact factor: 3.623

Review 6.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

7.  Hip arthroplasty in patients with cirrhosis of the liver.

Authors:  P H Hsieh; L H Chen; M S Lee; C H Chen; W E Yang; C H Shih
Journal:  J Bone Joint Surg Br       Date:  2003-08

8.  Risk factors for early revision after primary total hip arthroplasty in Medicare patients.

Authors:  Kevin J Bozic; Edmund Lau; Kevin Ong; Vanessa Chan; Steven Kurtz; Thomas P Vail; Harry E Rubash; Daniel J Berry
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

9.  Total knee arthroplasty in patients with liver cirrhosis.

Authors:  Lih-Yuann Shih; Chun-Ying Cheng; Chung-Hsun Chang; Kuo-Yao Hsu; Robert Wen-Wei Hsu; Hsin-Nung Shih
Journal:  J Bone Joint Surg Am       Date:  2004-02       Impact factor: 5.284

10.  Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease.

Authors:  Young-Wan Moon; Yong-Sik Kim; Soon-Yong Kwon; Shin-Yoon Kim; Seung-Jae Lim; Youn-Soo Park
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

View more
  17 in total

1.  Letter to the editor: Increased complication rates after hip and knee arthroplasty in patients with cirrhosis of the liver.

Authors:  Minghui Peng; Jianbao Jiao
Journal:  Clin Orthop Relat Res       Date:  2015-01-21       Impact factor: 4.176

Review 2.  Factors That Affect Outcome Following Total Joint Arthroplasty: a Review of the Recent Literature.

Authors:  Forrest H Schwartz; Jeffrey Lange
Journal:  Curr Rev Musculoskelet Med       Date:  2017-09

3.  Outcome analysis of hip or knee arthroplasty in patients with cirrhotic liver disease.

Authors:  Young-Jun Seol; Taek-Rim Yoon; Dong-Hyun Lee; Sun-Ho Lee; Kyung-Soon Park
Journal:  J Orthop       Date:  2017-01-04

4.  In-Hospital mortality varies by procedure type among cirrhosis surgery admissions.

Authors:  Nadim Mahmud; Zachary Fricker; Marina Serper; David E Kaplan; Kenneth D Rothstein; David S Goldberg
Journal:  Liver Int       Date:  2019-06-17       Impact factor: 5.828

5.  Impact of Cirrhosis on Resource Use and Inpatient Complications in Patients Undergoing Total Knee and Hip Arthroplasty.

Authors:  Jared M Newman; Nicholas K Schiltz; Christopher D Mudd; Caleb R Szubski; Alison K Klika; Wael K Barsoum
Journal:  J Arthroplasty       Date:  2016-04-27       Impact factor: 4.757

6.  Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing Colectomy.

Authors:  Matthew M Fleming; Fangfang Liu; Yawei Zhang; Kevin Y Pei
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

7.  Outcomes of Patients With Cirrhosis Undergoing Orthopedic Procedures: An Analysis of the Nationwide Inpatient Sample.

Authors:  Neehar D Parikh; Yu-Hui Chang; Elliot B Tapper; Amit K Mathur
Journal:  J Clin Gastroenterol       Date:  2019-10       Impact factor: 3.062

8.  Total joint arthroplasty in patients with chronic infectious liver disease.

Authors:  Jeremy N Truntzer; Kalpit N Shah; Derek R Jenkins; Lee E Rubin
Journal:  Arthroplast Today       Date:  2015-10-31

9.  Postoperative Risk of Hepatic Decompensation after Orthopedic Surgery in Patients with Cirrhosis.

Authors:  Eric M Nyberg; Michael Batech; T Craig Cheetham; Jose R Pio; Susan L Caparosa; Mary Alice Chocas; Anshuman Singh
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

Review 10.  Predictive models for identifying risk of readmission after index hospitalization for hip arthroplasty: A systematic review.

Authors:  Satish M Mahajan; Amey Mahajan; Chantal Nguyen; Justin Bui; Bruce T Abbott; Thomas F Osborne
Journal:  J Orthop       Date:  2020-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.